Rasna Therapeutics, Inc. (RASP)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue - - 314.00 1635.00 3471.00 4833.00
Gross Profit - - -314.00 -1635.00 -3471.00 -4833.00
Operating Expenses 4.23 Million 383.91 Thousand 247.81 Thousand 556.5 Thousand 915.17 Thousand 4.07 Million
Selling, General and Administrative Expenses 287.37 Thousand 300.07 Thousand 247.81 Thousand 556.5 Thousand 900.79 Thousand 3.74 Million
Research and Development Expenses 92.24 Thousand 83.84 Thousand 55.2 Thousand - 14.37 Thousand 324.6 Thousand
Other Expenses - - - 4.93 Million 75.22 Thousand 403.29 Million
Cost and Expenses 4.23 Million 383.91 Thousand 247.81 Thousand 556.5 Thousand 915.17 Thousand 4.07 Million
Operating Income -4.23 Million 141.08 Thousand -247.81 Thousand -5.42 Million -915.17 Thousand -4.07 Million
Interest Expense 212.97 Thousand 940.99 Thousand 515.9 Thousand 41.43 Thousand 27.56 Thousand -
Income Tax Expense - -113.31 Thousand 515.9 Thousand -3034.00 -7584.00 2093.00
Earnings before Tax -4.44 Million -686.58 Thousand -785.08 Thousand -5.34 Million -943.96 Thousand -4.07 Million
Net Income -4.44 Million -573.27 Thousand -1.3 Million -5.34 Million -936.38 Thousand -4.07 Million
Earnings Per Share Basic -0.01 -0.01 -0.02 -0.08 -0.01 -0.06
Earnings Per Share Diluted -0.01 -0.01 -0.02 -0.08 -0.01 -0.06
Weighted Average Shares Outstanding 444.25 Million 111.42 Million 68.9 Million 68.9 Million 68.9 Million 68.6 Million
Weighted Average Shares Outstanding (Diluted) 578.01 Million 111.42 Million 68.9 Million 68.9 Million 68.9 Million 68.6 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -379.62 Thousand 254.4 Thousand -247.5 Thousand -554.86 Thousand -912.92 Thousand -4.06 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts